Gain Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Gain Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Gain Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 303 %, a 11.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 303 -40.6 -11.8% Sep 30, 2024
Q2 2024 285 -142 -33.3% Jun 30, 2024
Q1 2024 292 -240 -45.2% Mar 31, 2024
Q4 2023 315 -354 -52.9% Dec 31, 2023
Q3 2023 344 -513 -59.8% Sep 30, 2023
Q2 2023 427 -601 -58.4% Jun 30, 2023
Q1 2023 532 -718 -57.4% Mar 31, 2023
Q4 2022 669 -898 -57.3% Dec 31, 2022
Q3 2022 857 -502 -37% Sep 30, 2022
Q2 2022 1.03K Jun 30, 2022
Q1 2022 1.25K Mar 31, 2022
Q4 2021 1.57K Dec 31, 2021
Q3 2021 1.36K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.